Skinhealth Systems (SKIN) revenue and earnings history
Skinhealth Systems reported revenue of $301M for fiscal 2025 (year ended Dec 31, 2025), −10.0% on the year before, and net income of −$9.52M.
Over 6 years, from fiscal 2019 to fiscal 2025, revenue grew at a compound rate of +10.3% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $301M−10.0% | −$20.8M | −$9.52M | $37.5M | $303K | $37.2M | $14.8M | $0 | — | $233M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Skinhealth Systems (SKIN) on OQRO.
Common questions
What was Skinhealth Systems's revenue in fiscal 2025?
$301M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 12, 2026. That is −10.0% on fiscal 2024 ($334M).
How fast has Skinhealth Systems's revenue grown?
From $167M in fiscal 2019 to $301M in fiscal 2025: a compound annual growth rate of +10.3% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Skinhealth Systems tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.